DNA X, Inc. Reports Second Quarter 2026 Financial Results
DNA X, Inc. reported its second quarter 2026 financial results. During the quarter, the company strengthened its balance sheet with $1.8 million in cash from new convertible debt, followed by an additional $5.0 million raised through the sale of preferred stock after the quarter ended.
Why it matters — A SONM watcher would care because the new capital raises indicate measures to strengthen the company's balance sheet and support its operations.